Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosis.

scientific article published in July 2008

Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1592/PHCO.28.7.883
P698PubMed publication ID18576903

P50authorTimothy SynoldQ78536675
P2093author name stringShanshan Liu
Gilbert J Burckart
Paul M Beringer
Xiyun Zhang
Stan Louie
Levita Hidayat
Bertrand Shapiro
Mark Gill
Jane Kriengkauykiat
Purush A Rao
P2860cites workVolume-regulated chloride channels associated with the human multidrug-resistance P-glycoproteinQ28186115
Absolute bioavailability and intracellular pharmacokinetics of azithromycin in patients with cystic fibrosisQ34228376
MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadineQ35803858
Pathogenesis of cystic fibrosisQ40486086
Can the enhanced renal clearance of antibiotics in cystic fibrosis patients be explained by P-glycoprotein transport?Q40729344
Identification of functionally variant MDR1 alleles among European Americans and African AmericansQ43705904
Disposition of drugs in cystic fibrosis. I. Sulfamethoxazole and trimethoprimQ45156538
Effect of the MDR1 C3435T variant and P-glycoprotein induction on dicloxacillin pharmacokinetics.Q45939354
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectcystic fibrosisQ178194
dicloxacillinQ2313471
P304page(s)883-894
P577publication date2008-07-01
P1433published inPharmacotherapyQ7180800
P1476titleLack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosis
P478volume28

Reverse relations

cites work (P2860)
Q50668713Clarification of P-glycoprotein inhibition-related drug-drug interaction risks based on a literature search of the clinical information.
Q57240383Four Decades of β-Lactam Antibiotic Pharmacokinetics in Cystic Fibrosis
Q92879801Novel Population Pharmacokinetic Approach to Explain the Differences between Cystic Fibrosis Patients and Healthy Volunteers via Protein Binding
Q57684555Solute Carrier (SLC) Family Transporters

Search more.